The Rome-based tech company is planning a wider rollout across Europe with a new archive service designed to preserve cinema heritage.
Biomea Fusion shares spiked on positive 52-week Phase II data for icovamenib in type 2 diabetes. Read why I rate BMEA stock a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback